Overview

Effects of the Contraceptive Implant in Women With Sickle Cell Disease

Status:
Not yet recruiting
Trial end date:
2024-02-15
Target enrollment:
Participant gender:
Summary
The objective of this study is to measure the acceptability and impact of the progestin implant on frequency of vaso-occlusive crises, quality of life, and hematologic parameters in women with SCD.
Phase:
Phase 4
Details
Lead Sponsor:
University of Pennsylvania
Treatments:
Etonogestrel